AQR Capital Management LLC Sells 1,079,783 Shares of Sotera Health (NASDAQ:SHC)

AQR Capital Management LLC lessened its stake in shares of Sotera Health (NASDAQ:SHC - Free Report) by 42.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,484,301 shares of the company's stock after selling 1,079,783 shares during the quarter. AQR Capital Management LLC owned about 0.52% of Sotera Health worth $20,157,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Barclays PLC increased its holdings in Sotera Health by 169.8% in the 3rd quarter. Barclays PLC now owns 473,597 shares of the company's stock valued at $7,909,000 after buying an additional 298,085 shares during the period. Retirement Systems of Alabama lifted its stake in Sotera Health by 20.8% during the third quarter. Retirement Systems of Alabama now owns 185,779 shares of the company's stock worth $3,103,000 after purchasing an additional 32,051 shares during the last quarter. GAMMA Investing LLC lifted its stake in Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock worth $56,000 after purchasing an additional 1,121 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Sotera Health by 2.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 51,940 shares of the company's stock valued at $711,000 after purchasing an additional 1,047 shares in the last quarter. Finally, Oak Thistle LLC acquired a new stake in Sotera Health in the fourth quarter valued at about $222,000. Institutional investors own 91.03% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on SHC. The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $14.00 to $17.00 in a report on Monday, May 5th. Barclays dropped their price objective on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Finally, Piper Sandler reduced their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $15.80.

Sotera Health Stock Down 0.8 %

NASDAQ:SHC traded down $0.10 on Friday, hitting $13.13. The stock had a trading volume of 780,945 shares, compared to its average volume of 1,196,016. Sotera Health has a 1 year low of $9.53 and a 1 year high of $17.08. The firm's fifty day simple moving average is $11.45 and its two-hundred day simple moving average is $12.93. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The stock has a market cap of $3.73 billion, a P/E ratio of 52.52 and a beta of 1.88.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.02. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business had revenue of $254.52 million for the quarter, compared to analysts' expectations of $245.56 million. During the same quarter in the previous year, the firm earned $0.13 earnings per share. The business's revenue was up 2.6% on a year-over-year basis. Analysts predict that Sotera Health will post 0.61 earnings per share for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.